TG Therapeutics Inc (TGTX)

Exchange
NASDAQ
Symbol
TGTX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
Country
USA

Stock price

At close: August 11, 2025

  • Open
    26.14
  • High
    27.37
  • Low
    25.28
  • Close
    26.39
  • Volume
    4,562,060

Financial ratios

Dec 31, 2024